Phase 1 Trial Suggests Tiziana’s Milciclib Benefits Mesothelioma Patients
News
A combination of Tiziana Life Sciences‘ milciclib and the intravenous chemotherapy Gemzar (gemcitabine) stabilized tumor growth in a small group of patients with advanced solid tumors, including mesothelioma, according to a ... Read more